Physician profile
Roman Grinberg
NPI 1437271418
$28,303.90
in general payments reported to CMS, 2019-2025
11 companies · $2,293 in 2025
The $2,293 reported for 2025 was more than what 83% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $234 · 2020: $4,130 · 2021: $329 · 2022: $717 · 2023: $3,208 · 2024: $17K · 2025: $2,293.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $16K · Food and Beverage: $3,569 · Travel and Lodging: $3,325.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $16,000.00 |
| Food and Beverage | $3,569.29 |
| Travel and Lodging | $3,324.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $20,516.58 | 2020-2024 | Da Vinci Surgical System |
| Davol INC. | $3,223.64 | 2021-2025 | Phasix Mesh, Bard 3dmax Mesh, Arista |
| Kerecis Limited | $3,167.09 | 2022-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Becton, Dickinson and Company | $371.84 | 2022-2025 | Phasix Mesh, Arista |
| Kci USA, INC. | $300.22 | 2020 | |
| W. L. Gore & Associates, INC. | $187.31 | 2025 | Gore Synecor Preperitoneal Biomaterial |
| Polynovo North America LLC | $165.40 | 2024 | Novosorb Btm |
| Acell, INC. | $133.56 | 2019 | |
| Boston Scientific Corporation | $120.68 | 2021 | |
| Mentor Worldwide LLC | $100.00 | 2019 | |
| Integra Lifesciences Corporation | $17.58 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roman Grinberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.